+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variability in oral bioavailability for uk 52831 a dihydropyridine calcium antagonist between the fed and fasted states



Variability in oral bioavailability for uk 52831 a dihydropyridine calcium antagonist between the fed and fasted states



British Journal of Clinical Pharmacology 33(2): 236P-237P




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034181531

Download citation: RISBibTeXText


Related references

Comparative oral bioavailability of azimilide dihydrochloride in the fed and fasted states. British Journal of Clinical Pharmacology 49(3): 279-282, 2000

Pharmacokinetics and estimated bioavailability of grapiprant, a novel selective prostaglandin E 2 receptor antagonist, after oral administration in fasted and fed dogs. New Zealand Veterinary Journal 65(1): 19-23, 2016

Sd 3211 a new non dihydropyridine calcium antagonist is as vasoselective as dihydropyridine calcium antagonists. Japanese Journal of Pharmacology 52(SUPPL 1): 282P, 1990

Enhancement of binding of the dihydropyridine calcium antagonist PN200-110 to human myometrial sarcolemma by the heterologous calcium antagonist diltiazem. Biochemical Pharmacology 36(7): 1003-1009, 1987

The effect of a dihydropyridine and a non-dihydropyridine calcium antagonist on plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential mild to moderate hypertension. European Heart Journal 21(Abstract Supplement): 608, August-September, 2000

Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects. European Journal of Clinical Pharmacology 68(12): 1595-1603, 2013

Differences in glomerular membrane permeability responses to a non-dihydropyridine and dihydropyridine calcium channel antagonist in patients with diabetic nephropathy A randomized, single-blind, two-year study. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 118A, Sept, 1997

Oral bioavailability of sulphadiazine and trimethoprim in fed and fasted pigs. Research in Veterinary Science 56(1): 48-52, 1994

Bioavailability of enrofloxacin after oral administration to fed and fasted pigs. Pharmacology & Toxicology. 80(5): 246-250, 1997

Bioavailability of penicillin V after oral administration to fed and fasted pigs. Journal of Veterinary Pharmacology and Therapeutics 17(2): 160-162, 1994

Mode of binding of nb 818 a 1 4 dihydropyridine calcium antagonist to the calcium channel of rat brain membranes. Japanese Journal of Pharmacology 46(SUPPL): 298P, 1988

Cardiovascular profile of MPC-1304, a novel dihydropyridine calcium antagonist: comparison with other calcium antagonists. Journal of Cardiovascular Pharmacology 22(1): 167-175, 1993

Binding profile to a calcium channel of mpc 1304 a novel dihydropyridine calcium antagonist. Japanese Journal of Pharmacology 59(SUPPL 1): 229P, 1992

Effects of nz 105 a novel 1 4 dihydropyridine calcium antagonist on receptor binding and calcium 45 uptake. Japanese Journal of Pharmacology 52(SUPPL 1): 345P, 1990

Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities Novel calcium-antagonist 2- aminoethyl-5-. Chemical & Pharmaceutical Bulletin (Tokyo) 40(9): 2362-2369, 1992